BPC 157 and Standard Angiogenic Growth Factors Key Findings: BPC-157, when compared to standard peptidergic angiogenic growth factors (EGF, FGF, VEGF), has been effective in all models of acute/chronic injury of the gastrointestinal tract, whether administered intraperitoneally, per-orally, or locally
BPC-157 tends to work more locally when injected near injury sites
This article summarizes published preclinical findings and analytical-quality considerations
We strongly recommend writing the date you first opened it directly on the vials label
Store Properly If you are using injectable BPC 157, proper storage is important to maintain its efficacy
Starting injections without a proper diagnosis is just guessing, and it could end up hiding other serious health issues